You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

allogeneic hematopoietic stem cell transplant (allo-HSCT)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Reconstitution After Allo-HSCT and Blinatumomab

Not yet recruiting
  • Leukemia, Lymphoid
  • (no location specified)
Oct 3, 2023

Leukemia Trial (Prehabilitation)

Not yet recruiting
  • Leukemia
  • Prehabilitation
  • (no location specified)
Dec 5, 2022

CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

Not yet recruiting
  • CMV Infection
  • +2 more
  • Virus specific T cells
  • (no location specified)
Oct 4, 2023

MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)

Not yet recruiting
  • MPS-IH (Hurler Syndrome)
  • Experimental: OTL-203
  • Active Comparator: Allo-HSCT
  • Oakland, California
  • +6 more
Nov 27, 2023

CARPET Prognostic Model for Septic Shock After Allo-HSCT

Not yet recruiting
  • Stem Cell Transplant Complications
  • CARPET prognostic model
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Aug 31, 2023

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Hematologic Diseases Trial in Palo Alto (biological, device, drug)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • +2 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Mar 25, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2022

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +3 more
  • Allogeneic Bone Marrow Transplantation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Alterations in Intestinal Microbiota, Metabolites, and Immune

Recruiting
  • Graft Vs Host Disease
  • Blood Sample
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Nov 16, 2023

Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))

Not yet recruiting
  • Transplantation, Hematopoietic Stem Cell
  • Biological samples (blood and oral fluid)
  • Lyon, France
    Hôpital de la Croix Rousse - service des maladies infectieuses e
Jul 7, 2023

Brain Neuronal Networks, Chemosensory and Trigeminal Functions

Recruiting
  • Hematopoietic Stem Cell Transplantation
    • Oslo, Norway
      University of Oslo
    Aug 21, 2023

    Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell

    Completed
    • Acute Lymphoblastic Leukemia in Remission
    • +6 more
    • Allogeneic Bone Marrow Transplantation
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 15, 2021

    Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid

    Recruiting
    • Previously Treated Myelodysplastic Syndrome
    • +3 more
    • Fludarabine Phosphate
    • +9 more
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    Jan 7, 2022

    Allo-HSCT as First-line Consolidation in High-risk PTCL

    Recruiting
    • T Cell Lymphoma
      • Beijing, China
        Peking University People's Hospital
      Jul 31, 2022

      Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +4 more
        • (no location specified)
        Nov 1, 2023

        The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or

        Recruiting
        • Acute Leukemia
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • Guangzhou, Guangdong, China
          Department of Hematology,Nanfang Hospital, Southern Medical Univ
        Oct 28, 2022

        Acute Leukemia, Relapse, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (Sorafenib)

        Recruiting
        • Acute Leukemia
        • +2 more
        • Guangzhou, Guangdong, China
          Department of Hematology,Nanfang Hospital, Southern Medical Univ
        Oct 30, 2021

        Tumor, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Sham VR, Active VR)

        Not yet recruiting
        • Neoplasm
        • Caregivers
        • Sham VR
        • Active VR
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jun 26, 2023

        Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

        Recruiting
        • Hematopoietic Malignancy
        • +2 more
        • Umbilical Cord Blood Transplantation
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow university
        Nov 6, 2023

        The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

        Recruiting
        • Acute Myeloid Leukemia With FLT3/ITD Mutation
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • Guangzhou, Guangdong, China
          Department of Hematology,Nanfang Hospital, Southern Medical Univ
        Oct 25, 2022

        The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

        Recruiting
        • Acute Myeloid Leukemia With FLT3/ITD Mutation
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • Guangzhou, Guangdong, China
          Department of Hematology,Nanfang Hospital, Southern Medical Univ
        Oct 25, 2022

        Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

        Not yet recruiting
        • Hematopoietic Stem Cell Transplantation
        • Hematologic Malignancy
        • CliniMACS®
        • (no location specified)
        Oct 17, 2023